Cart
sales@molnova.com
LTI-291
CAS No. 1919820-28-2
LTI-291( LTI-291 | LTI 291 | LTI291 )
Catalog No. M18176 CAS No. 1919820-28-2
LTI-291 is a glucocerebrosidase (Gcase) activator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 53 | In Stock |
|
| 5MG | 87 | In Stock |
|
| 10MG | 147 | In Stock |
|
| 25MG | 295 | In Stock |
|
| 50MG | 475 | In Stock |
|
| 100MG | 692 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLTI-291
-
NoteResearch use only, not for human use.
-
Brief DescriptionLTI-291 is a glucocerebrosidase (Gcase) activator.
-
DescriptionLTI-291 is a glucocerebrosidase (Gcase) activator for treatment of Parkinson's disease (PD).
-
In Vitro——
-
In Vivo——
-
SynonymsLTI-291 | LTI 291 | LTI291
-
PathwayOthers
-
TargetOther Targets
-
Recptorβ-glucosidase
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1919820-28-2
-
Formula Weight358.49
-
Molecular FormulaC20H30N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 139.48 mM;
-
SMILESO=C(C1=C2N=C(C)C=C(C)N2N=C1)N[C@H]3CC[C@H](OCCCCC)CC3
-
Chemical Name5,7-Dimethyl-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (trans-4-pentyloxy-cyclohexyl)-amide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Renato T. Skerlj, et al. Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds. WO 2017192841 A1.
molnova catalog
related products
-
[D-Phe12]-Bombesin
[D-Phe12]-Bombesin is a derivative of Bombesin and an antagonist for bombesin receptor with Ki of 4.7 μM. [D-Phe12]-Bombesin inhibits the Bombesin -induced amylase release, with IC50 of 4 μM.
-
Glycyrrhizinic acid ...
Glycyrrhizinic acid potassium salt?can reduce ventricular arrhythmias caused by veratrol.
-
ELA-21 (human)
High affinity apelin receptor agonist. Binds apelin receptors in left ventricle from normal and pulmonary arterial hypertensive (PAH) hearts (pKi values are 9.31 and 9.46, respectively). Bioactive fragment of ELA-32. Inhibits forskolin-induced cAMP production and stimulates β-arrestin recruitment in vitro.
